ANDA 75885, held by Hospira. Milrinone Lactate.
As of Nov 16, 2026, ANDA 75885 (Milrinone Lactate In Dextrose 5% In Plastic Container), held by Hospira, was first approved by FDA on May 28, 2002, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 28, 2002 | Original application | Approved | None posted |
| Milrinone Lactate In Dextrose 5% In Plastic ContainerEQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) · injectable;injection | Milrinone Lactate | Discontinued |
| Milrinone Lactate In Dextrose 5% In Plastic ContainerEQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) · injectable;injection | Milrinone Lactate | Discontinued |
| Jul 26, 2021 | Supplement 20Labeling · Standard review | Approved | None posted |
| Feb 7, 2008 | Supplement 9Labeling | Approved | None posted |
| May 28, 2002 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters